SIAPS Program in DRC Hosts MSH Vice President

MSH Vice President of the Center for Pharmaceutical Management (CPM), Douglas Keene, traveled to DRC last month to meet with SIAPS Country Project Director Philippe Tshiteta and important stakeholders in the country’s health sector. Mr. Keene and Mr. Tshiteta held a consultation with the Country Representative of the World Health Organization, Dr. Joseph Cabore. Dr.Cabore … Read more

Advancing the Adoption of the DRC’s Essential Medicines List

In a three-day workshop jointly sponsored by the US Agency for International Development (USAID)-funded SIAPS and the World Health Organization (WHO), stakeholders adopted the essential medicines list (EML) for the Democratic Republic of Congo (DRC). The stakeholder consultation was carried out with the support of the DRC’s Ministry of Public Health and Pharmaceutical Directorate. Every … Read more

Video: Meet Chinwe Owunna

Reposted from Chinwe Owunna of Management Sciences for Health (MSH) describes the active surveillance approach used by the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program in Swaziland to increase understanding of medicines safety and risk/benefit context for TB and HIV patients. Watch video More about SIAPS

Information and Action to Address the Serious Threat of Antimicrobial Resistance

Malaika Ludman, SIAPS Technical Advisor; Claire Tindula, SIAPS Project Associate Does antimicrobial resistance mean the end of modern medicine as we know it? Not quite yet. However, in a report recently released on global surveillance of antimicrobial resistance (AMR), the World Health Organization (WHO) warned that “a post-antibiotic era – in which common infections and … Read more

Acting on the Call: Ending Preventable Maternal and Child Deaths through Pharmaceutical Systems Strengthening

Sheena Patel, Technical Advisor, and Kiley Workman, Project Associate Although the global community has had significant success in reducing maternal and child deaths in the past two decades, they continue to die of preventable causes at an alarming rate. This is especially pronounced for the most vulnerable and hard-to-reach populations. Universal access to maternal, newborn, … Read more

Enhancing Health Outcomes for Chronic Diseases in Resource-Limited Settings by Improving the Use of Medicines: The Role of Pharmaceutical Care

In low- and middle-income countries (LMICs), health systems have historically focused on the prevention and treatment of highly prevalent and frequently fatal acute infectious illnesses such as malaria, diarrhea, and respiratory infections. However, due to changes in health risks, LMIC are experiencing an increasing burden of chronic non-communicable diseases (NCDs) in addition to the existing … Read more

Improving Medicines Benefit Management for Universal Health Coverage Programs: A Conversation with Kwesi Eghan

Reposted from Used appropriately, medicines save lives, decrease effect or cure diseases, and improve quality of life. Medicines are also key determinants of health care quality, and can be among the most cost-effective uses of scarce health care resources. At the same time, management of medicines is a major source of inefficiencies in health care … Read more

Scaling Up Integrated Community Case Management in Burundi

The Burundi SIAPS team, in a one-MSH initiative led by Pascaline Harerimana and assisted by SIAPS Principal Technical Advisor Jane Briggs, supported the Burundi’s Ministry of Health (MoH) National Malaria Control Program to evaluate their pilot of community case management of malaria.  The objective was to inform the requirements for expanding services to include malaria, diarrhea, … Read more